Updated on 16 September 2026
ELEMENTARY - compounds validation
PostDoc fellow at Istituto Auxologico Italiano
Milan, Italy
About
We offer access to a patient-derived preclinical screening platform for rare endocrine tumors (currently under validation for medullary thyroid carcinoma and neuroendocrine tumors). We are seeking partners wishing to test compounds, including approved drugs, repurposed molecules, or novel candidates, on clinically representative tumor models in an exploratory, research-collaboration framework.
Similar opportunities
Product
ORGANoro - A cardiac organoid based platform for drug screening and personalized medicine
- Buyer
- License partner
- Demonstration / Pilot projects
Beatrice Bassetti
Head Technology Transfer Office at Centro Cardiologico Monzino IRCCS
Milano, Italy
Expertise
Branched peptide for antiviral use
Alessandra Romeo
Knowledge Transfer Manager at Università degli Studi di Siena
Siena, Italy